Dipeptidyl peptidase IV (DP IV, CD26) and aminopeptidase N (APN, CD13) as regulators of T cell function and targets of immunotherapy in CNS inflammation.
Biton
Aliza
A
Department of Pathology, Faculty of Medicine, Hebrew University-Hadassah Medical School, POB 12272, 91120 Jerusalem, Israel.
Bank
Ute
U
Täger
Michael
M
Ansorge
Siegfried
S
Reinhold
Dirk
D
Lendeckel
Uwe
U
Brocke
Stefan
S
D000818:Animals; D018826:CD13 Antigens / Q000378:metabolism*; D018819:Dipeptidyl Peptidase 4 / Q000378:metabolism*; D004681:Encephalomyelitis, Autoimmune, Experimental / Q000201:enzymology / Q000276:immunology / Q000628:therapy; D005260:Female; D006801:Humans; D007167:Immunotherapy; D051379:Mice; D015842:Serine Proteinase Inhibitors / Q000378:metabolism / Q000627:therapeutic use; D013601:T-Lymphocytes / Q000276:immunology*
D015842:Serine Proteinase Inhibitors; D018826:CD13 Antigens; D018819:Dipeptidyl Peptidase 4